These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 16884992

  • 1. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
    Dell'Utri D, Passariello M.
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):570-2. PubMed ID: 16884992
    [No Abstract] [Full Text] [Related]

  • 2. The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm.
    Wahlgren CM, Swedenborg J.
    Eur J Vasc Endovasc Surg; 2003 Aug; 26(2):221-2. PubMed ID: 12917843
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J, Goral A, Paluszkiewicz P, Przesmycki K, Kotarski J.
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [Abstract] [Full Text] [Related]

  • 4. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections].
    Pajares A, Larrea L.
    Rev Esp Anestesiol Reanim; 2006 Apr; 53(4):266-7; author reply 268. PubMed ID: 16711505
    [No Abstract] [Full Text] [Related]

  • 5. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.
    J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
    [Abstract] [Full Text] [Related]

  • 6. Invited commentary.
    Hoch JR.
    J Vasc Surg; 2011 Apr; 53(4):1037-8. PubMed ID: 21439457
    [No Abstract] [Full Text] [Related]

  • 7. Recombinant activated factor VII in abdominal aortic emergencies.
    Abi Saad GS, Alaeddine MH, Khalil IM, Bou-Khalil PK, Musallam KM, Taher AT.
    Ann Surg; 2009 Apr; 249(4):692; author reply 692-3. PubMed ID: 19300206
    [No Abstract] [Full Text] [Related]

  • 8. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
    Hirasaki Y, Suematsu Y, Yasuda T, Tajima K.
    Anesth Analg; 2010 Jan 01; 110(1):261-2. PubMed ID: 20023190
    [No Abstract] [Full Text] [Related]

  • 9. Recombinant activated factor VII and aortic surgery.
    Thompson JF.
    Eur J Vasc Endovasc Surg; 2013 Jun 01; 45(6):626. PubMed ID: 23531347
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant activated factor VII in the management of massive obstetric bleeding.
    Palomino MA, Chaparro MJ, de Elvira MJ, Curiel EB.
    Blood Coagul Fibrinolysis; 2006 Apr 01; 17(3):226-7. PubMed ID: 16575264
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Gielen-Wijffels SE, van Mook WN, Ramsay G.
    Ned Tijdschr Geneeskd; 2003 Mar 01; 147(9):419. PubMed ID: 12661464
    [No Abstract] [Full Text] [Related]

  • 12. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
    Al-Ruzzeh S, Mahmoud A, Shah S, O'Regan D.
    Ann Thorac Surg; 2007 Jan 01; 83(1):355; author reply 355-6. PubMed ID: 17184710
    [No Abstract] [Full Text] [Related]

  • 13. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C, Lucía JF.
    Am J Hematol; 2007 Mar 01; 82(3):246-7. PubMed ID: 16924645
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
    Silver DA, D'Ambra MN.
    Crit Care Med; 2007 Jul 01; 35(7):1782-3. PubMed ID: 17581365
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
    El Kinge AR, Mahfouz RA, Shamseddine AI, Taher AT.
    Blood Coagul Fibrinolysis; 2007 Sep 01; 18(6):577-9. PubMed ID: 17762536
    [Abstract] [Full Text] [Related]

  • 16. [Application of recombinant activated factor VII in gynecological intervention (case report)].
    Nacheva A, Gateva Zh, Atanasova V.
    Akush Ginekol (Sofiia); 2004 Sep 01; 43 Suppl 4():3-5. PubMed ID: 15673003
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.
    Ann Thorac Surg; 2008 Mar 01; 85(3):836-44. PubMed ID: 18291152
    [Abstract] [Full Text] [Related]

  • 18. Primary autologous superficial femoral vein reconstruction of an emergency, infected, ruptured aortic aneurysm.
    Thrush S, Watts A, Fraser SC, Edmondson RA.
    Eur J Vasc Endovasc Surg; 2001 Dec 01; 22(6):557-8. PubMed ID: 11735207
    [No Abstract] [Full Text] [Related]

  • 19. Failure of recombinant FVIIa as treatment for abdominal bleeding in acquired hemophilia.
    Makris M, Hampton KK, Preston EE.
    Am J Hematol; 2001 Jan 01; 66(1):67-8. PubMed ID: 11426500
    [No Abstract] [Full Text] [Related]

  • 20. Use of recombinant activated factor VII after axillofemoral bypass grafting.
    Cheng CA, Ho AM.
    Anaesth Intensive Care; 2006 Jun 01; 34(3):375-8. PubMed ID: 16802495
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.